Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison Mann

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Social Science Research|October 5, 2013
Trends in gender segregation in the choice of science and engineering majorsAllison Mann, Thomas A Diprete
Currents in Pharmacy Teaching & Learning|May 2, 2019
Evaluation of pharmacy student perceptions and stereotypes of healthcare professionals before and after an internal medicine advanced pharmacy practice experienceLauren Biehle, Allison Mann, Lanae Fox
Frontiers in Psychology|March 13, 2015
The role of school performance in narrowing gender gaps in the formation of STEM aspirations: a cross-national studyAllison Mann, Joscha Legewie, Thomas A DiPrete
Digital Health|February 28, 2022
Physician centricity in the deployment of digital solutions for neurological conditionsGraham B Jones, Jason Freeman, Allison Mann, et al.
Journal of Child Neurology|December 4, 2009
Safety and tolerability of rufinamide in children with epilepsy: a pooled analysis of 7 clinical studiesJames W Wheless, Joan Conry, Gregory Krauss, et al.
Epilepsy Research|January 12, 2010
A 24-week multicenter, randomized, double-blind, parallel-group, dose-ranging study of rufinamide in adults and adolescents with inadequately controlled partial seizuresChristian E Elger, Hermann Stefan, Allison Mann, et al.
Epilepsia|October 5, 2010
A randomized, double-blind, placebo-controlled, parallel-group study of rufinamide as adjunctive therapy for refractory partial-onset seizuresVictor Biton, Gregory Krauss, Blanca Vasquez-Santana, et al.
Epilepsia|June 4, 2009
Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: a randomized placebo-controlled trialMartin J Brodie, William E Rosenfeld, Blanca Vazquez, et al.
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|June 10, 2017
Marijuana Use in the Elderly: Implications and ConsiderationsTracy D Mahvan, Michelle L Hilaire, Allison Mann, et al.
Journal of Child and Adolescent Psychopharmacology|March 9, 2007
A pilot evaluation of the safety, tolerability, pharmacokinetics, and effectiveness of memantine in pediatric patients with attention-deficit/hyperactivity disorder combined typeRobert L Findling, Nora K McNamara, Robert J Stansbrey, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Social Science Research|October 5, 2013
Trends in gender segregation in the choice of science and engineering majorsAllison Mann, Thomas A Diprete
Currents in Pharmacy Teaching & Learning|May 2, 2019
Evaluation of pharmacy student perceptions and stereotypes of healthcare professionals before and after an internal medicine advanced pharmacy practice experienceLauren Biehle, Allison Mann, Lanae Fox
Frontiers in Psychology|March 13, 2015
The role of school performance in narrowing gender gaps in the formation of STEM aspirations: a cross-national studyAllison Mann, Joscha Legewie, Thomas A DiPrete
Digital Health|February 28, 2022
Physician centricity in the deployment of digital solutions for neurological conditionsGraham B Jones, Jason Freeman, Allison Mann, et al.
Journal of Child Neurology|December 4, 2009
Safety and tolerability of rufinamide in children with epilepsy: a pooled analysis of 7 clinical studiesJames W Wheless, Joan Conry, Gregory Krauss, et al.
Epilepsy Research|January 12, 2010
A 24-week multicenter, randomized, double-blind, parallel-group, dose-ranging study of rufinamide in adults and adolescents with inadequately controlled partial seizuresChristian E Elger, Hermann Stefan, Allison Mann, et al.
Epilepsia|October 5, 2010
A randomized, double-blind, placebo-controlled, parallel-group study of rufinamide as adjunctive therapy for refractory partial-onset seizuresVictor Biton, Gregory Krauss, Blanca Vasquez-Santana, et al.
Epilepsia|June 4, 2009
Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: a randomized placebo-controlled trialMartin J Brodie, William E Rosenfeld, Blanca Vazquez, et al.
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|June 10, 2017
Marijuana Use in the Elderly: Implications and ConsiderationsTracy D Mahvan, Michelle L Hilaire, Allison Mann, et al.
Journal of Child and Adolescent Psychopharmacology|March 9, 2007
A pilot evaluation of the safety, tolerability, pharmacokinetics, and effectiveness of memantine in pediatric patients with attention-deficit/hyperactivity disorder combined typeRobert L Findling, Nora K McNamara, Robert J Stansbrey, et al.
Pageof 2